Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 5/20 | 0.44 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | SRC | P12931 | 1/20 | 0.44 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.44 |
| ▸ | GRM8 | O00222 | 1/20 | 0.41 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.40 |
| ▸ | MEN1 | O00255 | 5/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.40 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.40 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.40 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28688103 | 1.00 | TDP1 (0.44) | TDP1NR1I2PTGS1ADRA1ALMNA | |
| SCHEMBL3112337 | 1.00 | TDP1 (0.44) | TDP1NR1I2PTGS1ADRA1ALMNA | |
| Iodide SCHEMBL27294834 | 0.98 | TDP1 (0.43) | TDP1NR1I2PTGS1ADRA1ALMNA | |
| Methane SCHEMBL20292606 | 0.98 | TDP1 (0.43) | TDP1NR1I2PTGS1ADRA1ALMNA | |
| SCHEMBL14935915 | 0.83 | CYP2D6 (0.48) | LMNASRCKMT2AMEN1CYP2C9 | |
| SCHEMBL2939473 | 0.83 | CYP2D6 (0.48) | LMNASRCKMT2AMEN1CYP2C9 | |
| Methane SCHEMBL5182249 | 0.82 | CYP2D6 (0.46) | LMNASRCKMT2AMEN1CYP2C9 | |
| Methane SCHEMBL5182658 | 0.82 | CYP2D6 (0.46) | LMNASRCKMT2AMEN1CYP2C9 | |
| SCHEMBL3666840 | 0.79 | SRC (0.47) | TDP1PTGS1ADRA1ALMNASRC | |
| SCHEMBL6046193 | 0.79 | TDP1 (0.47) | TDP1NR1I2PTGS1ADRA1ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1307 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260049178-A1 | CROSSLINKING AGENTS AND MEDICAL HYDROGELS FORMED THEREFROM | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2026-02-19 | — | — | US | claimed |
| EP-4644570-A1 | HELICASE MUTANT, AND PREPARATION METHOD THEREFOR AND USE THEREOF IN HIGH-THROUGHPUT SEQUENCING | BGI Shenzhen (CN) | 2025-11-05 | — | — | EP | claimed |
| US-20250243472-A1 | MODIFIED HELICASES | OXFORD NANOPORE TECHNOLOGIES PLC (GB) | 2025-07-31 | — | — | US | claimed |
| CN-119574735-A | Method for detecting organic iodine in seaweed | 益盐堂（应城）健康盐制盐有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-119104644-A | Analysis method for determining organic iodine in seaweed iodized salt by using amino acid analyzer | 江苏省食品药品监督检验研究院(江苏省食品质量安全监控中心) | 2024-12-10 | — | — | CN | claimed |
| US-20240400672-A1 | NOVEL MONOCLONAL ANTIBODIES DIRECTED AGAINST L-THYROXINE AND DIAGNOSTIC USES THEREOF | F. HOFFMANN-LA ROCHE AG (CH) | 2024-12-05 | — | — | US | claimed |
| CN-118688315-A | Multichannel high-coverage synchronous quantification method for amino-containing and hydroxyl-containing compounds | 复旦大学 | 2024-09-24 | — | — | CN | claimed |
| EP-4430074-A1 | NOVEL MONOCLONAL ANTIBODIES DIRECTED AGAINST L-THYROXINE AND DIAGNOSTIC USES THEREOF | F. Hoffmann-La Roche AG (CH) | 2024-09-18 | — | — | EP | claimed |
| WO-2024138422-A1 | PIN DOMAIN, HELICASE CONTAINING SAME, PREPARATION METHOD FOR PIN DOMAIN, AND USE OF PIN DOMAIN | 深圳华大生命科学研究院 | 2024-07-04 | — | — | WO | claimed |
| WO-2024138632-A1 | HELICASE, PREPARATION METHOD THEREFOR AND USE THEREOF IN SEQUENCING | 深圳华大生命科学研究院 | 2024-07-04 | — | — | WO | claimed |
| WO-1999015136-A1 | REDUCTION OF HAIR GROWTH | THE GILLETTE COMPANY (US) | 1999-04-01 | — | — | WO | claimed |
| EP-0672148-A1 | METHOD FOR MAKING STABLE, EXTRACELLULAR TYROSINASE AND SYNTHESIS OF POLYPHENOLIC POLYMERS THEREFROM | Biosource Technologies, Inc. (US) | 1995-09-20 | — | — | EP | claimed |
| US-5340734-A | In vitro biosynthesis the melanins in presence of a substrate consisting of tyrosine binding single amino acid, a dipeptide or an oligopeptide | BIOSOURCE GENETICS CORPORATION (US) | 1994-08-23 | — | — | US | claimed |
| WO-1994012644-A2 | METHOD FOR MAKING STABLE, EXTRACELLULAR TYROSINASE AND SYNTHESIS OF POLYPHENOLIC POLYMERS THEREFROM | BIOSOURCE GENETICS CORPORATION (US) | 1994-06-09 | — | — | WO | claimed |
| EP-0547065-A4 | MELANIN PRODUCTION BY TRANSFORMED MICROORGANISMS | — | 1993-09-15 | — | — | EP | claimed |
| EP-0547065-A1 | MELANIN PRODUCTION BY TRANSFORMED MICROORGANISMS | Biosource Technologies, Inc. (US) | 1993-06-23 | — | — | EP | claimed |
| WO-1992000373-A1 | MELANIN PRODUCTION BY TRANSFORMED MICROORGANISMS | BIOSOURCE GENETICS CORPORATION (CA) | 1992-01-09 | — | — | WO | claimed |
| EP-0103784-B1 | CATALYZED COLORIMETRIC AND FLUOROMETRIC SUBSTRATES FOR PEROXIDASE ENZYME DETERMINATIONS | ENZYME TECHNOLOGY COMPANY (US) | 1988-01-07 | — | — | EP | claimed |
| US-4521511-A | SUBSTITUTED PHENOLS AS ACCELERATOR | ENZYME TECHNOLOGY COMPANY (US) | 1985-06-04 | — | — | US | claimed |
| EP-0103784-A2 | Catalyzed colorimetric and fluorometric substrates for peroxidase enzyme determinations | ENZYME TECHNOLOGY COMPANY (US) | 1984-03-28 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260049178-A1 | CROSSLINKING AGENTS AND MEDICAL HYDROGELS FORMED THEREFROM | NPPA, MACF1, IGF1R | TDP1 3434/4885NR1I2 3023/4885PTGS1 2222/4885 |
| US-20240400672-A1 | NOVEL MONOCLONAL ANTIBODIES DIRECTED AGAINST L-THYROXINE AND DIAGNOSTIC USES THEREOF | IGLV6-57, THRB, TSHR | TDP1 3296/4885NR1I2 4071/4885PTGS1 4855/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.